LBP Antikörper
Kurzübersicht für LBP Antikörper (ABIN343175)
Target
Alle LBP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human LBP (Lipopolysaccaride binding protein). The antibody don't block LPS binding to membrane bound CD14.
-
Kreuzreaktivität
- Rind (Kuh), Hund, Pferd, Kaninchen
-
Aufreinigung
- Protein A affinity column
-
Immunogen
- native human LBP
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA, Immune histology at paraffin sections, LBP inhibition studies, Western Blot. No inhibition of LPS binding to membrane bound CD14 Binding titre at human LBP- ELISA: 1:10.000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with bidistilled water
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.12
-
Konservierungsmittel
- Without preservative
-
Lagerung
- -20 °C,-80 °C
-
-
-
: "The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity." in: Immunity, Vol. 39, Issue 4, pp. 647-60, (2013) (PubMed).
: "Lipopolysaccharide-binding protein: Local expression in bovine extrahepatic tissues." in: Veterinary immunology and immunopathology, (2010) (PubMed).
: "Local expression of lipopolysaccharide-binding protein in human gingival tissues." in: Journal of periodontal research, Vol. 39, Issue 4, pp. 242-8, (2004) (PubMed).
-
-
- LBP (Lipopolysaccharide Binding Protein (LBP))
-
Andere Bezeichnung
- Lipopolysaccharide (LPS)-Binding Protein (LBP)
-
Hintergrund
- Background: Natural Lipopolysccaride Binding Protein (LBP) is a 58KD glycoprotein produced in liver. It binds at lipid A of LPS with high affinity (10-9M) and reduced the cellular LPS effects at CD14+ cells (IL1ß, IL6, TNFα). It acts as opsonin for GRAM negative cells, LPS, neutrophiles and granulocytes.
-
Molekulargewicht
- ~58kDa
-
Gen-ID
- 3929
-
NCBI Accession
- NP_004130
-
UniProt
- P18428
-
Pathways
- TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades, Monocarboxylic Acid Catabolic Process
Target
-